Reversible posterior leukoencephalopathy syndrome and bevacizumab - PubMed (original) (raw)
. 2006 Mar 2;354(9):980-2; discussion 980-2.
- PMID: 16514715
Reversible posterior leukoencephalopathy syndrome and bevacizumab
Cevher Ozcan et al. N Engl J Med. 2006.
No abstract available
Similar articles
- Reversible posterior leukoencephalopathy syndrome and bevacizumab.
Glusker P, Recht L, Lane B. Glusker P, et al. N Engl J Med. 2006 Mar 2;354(9):980-2; discussion 980-2. doi: 10.1056/NEJMc052954. N Engl J Med. 2006. PMID: 16510760 No abstract available. - Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer.
Allen JA, Adlakha A, Bergethon PR. Allen JA, et al. Arch Neurol. 2006 Oct;63(10):1475-8. doi: 10.1001/archneur.63.10.1475. Arch Neurol. 2006. PMID: 17030665 - Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome?
Mir O, Mouthon L, Alexandre J, Mallion JM, Deray G, Guillevin L, Goldwasser F. Mir O, et al. J Natl Cancer Inst. 2007 Jan 3;99(1):85-6. doi: 10.1093/jnci/djk011. J Natl Cancer Inst. 2007. PMID: 17202119 No abstract available. - Bevacizumab in the treatment of breast cancer.
Koutras AK, Fountzilas G, Makatsoris T, Peroukides S, Kalofonos HP. Koutras AK, et al. Cancer Treat Rev. 2010 Feb;36(1):75-82. doi: 10.1016/j.ctrv.2009.10.007. Epub 2009 Nov 22. Cancer Treat Rev. 2010. PMID: 19932567 Review. - Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.
Sandler AB, Johnson DH, Herbst RS. Sandler AB, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4258s-4262s. doi: 10.1158/1078-0432.CCR-040023. Clin Cancer Res. 2004. PMID: 15217970 Review.
Cited by
- Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.
Cross SN, Ratner E, Rutherford TJ, Schwartz PE, Norwitz ER. Cross SN, et al. Rev Obstet Gynecol. 2012;5(1):2-8. Rev Obstet Gynecol. 2012. PMID: 22582121 Free PMC article. - Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.
Sunshine SB, Dallabrida SM, Durand E, Ismail NS, Bazinet L, Birsner AE, Sohn R, Ikeda S, Pu WT, Kulke MH, Javaherian K, Zurakowski D, Folkman JM, Rupnick M. Sunshine SB, et al. Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11306-11. doi: 10.1073/pnas.1203275109. Epub 2012 Jun 25. Proc Natl Acad Sci U S A. 2012. PMID: 22733742 Free PMC article. - Hypertensive Cardiotoxicity in Cancer Treatment-Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies-Epidemiology, Incidence, and Pathophysiology.
Chung R, Tyebally S, Chen D, Kapil V, Walker JM, Addison D, Ismail-Khan R, Guha A, Ghosh AK. Chung R, et al. J Clin Med. 2020 Oct 18;9(10):3346. doi: 10.3390/jcm9103346. J Clin Med. 2020. PMID: 33081013 Free PMC article. Review. - Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma.
Hadj JO, Braven RD, Tillier C, Schrijver HM, Verheul HM, VAN DER Vliet HJ. Hadj JO, et al. Oncol Lett. 2012 Jun;3(6):1293-1296. doi: 10.3892/ol.2012.646. Epub 2012 Mar 16. Oncol Lett. 2012. PMID: 22783436 Free PMC article. - New developments in the pathogenesis of preeclampsia.
Naljayan MV, Karumanchi SA. Naljayan MV, et al. Adv Chronic Kidney Dis. 2013 May;20(3):265-70. doi: 10.1053/j.ackd.2013.02.003. Adv Chronic Kidney Dis. 2013. PMID: 23928392 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources